No Data
No Data
Longeveron Inc. CEO Shares 2024 Progress and Strategic Goals for 2025 in Shareholder Letter
Longeveron Issues Letter To Shareholders
Longeveron: Will Need Additional Cap to Achieve Business Strategy and Objectives >LGVN
Longeveron: In 2025, Will Continue Focusing Efforts on Two of Our Most Promising Programs, HLHS and Alzheimer's Disease >LGVN
Longeveron: Strategic Plan Is Built on the Strength of the Science Underlying Our Stem Cell Therapy Laromestrocel >LGVN
Longeveron: Working to Effectively Advance Development Programs While Managing Expenses and Cap >LGVN